Induction of T cell anergy by liposomes with incorporated major histocompatibility complex (MHC) II/peptide complexes.

Pharm Res

Department of Pharmaceutics, Faculty of Pharmacy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands.

Published: June 2000

Purpose: The aim of this study was to use small unilamellar liposomes with incorporated MHC II/peptide complexes as a carrier system for multivalent antigen presentation to CD4 + T cells.

Methods: Purified peptide pre-loaded MHC II molecules were incorporated into small unilamellar liposomes and tested for their ability to activate A2b T cells. The outcome of T cell activation by such liposomes in the absence of accessory cells was tested via flow cytometry and a T cell anergy assay.

Results: Provided the presence of external co-stimulation, MHC II/ peptide liposomes were able to induce proliferation of the A2b T cell clone. More importantly incubation of these T cells with MHC II/ peptide liposomes in the absence of co-stimulation did not induce proliferation, however, a MHC/peptide ligand-density dependent down-regulation of the TCR was observed. Interestingly, when T cells after incubation with the MHC II/peptide liposomes were restimulated with their specific antigen in the presence of professional APC, these cells were anergic.

Conclusions: We propose MHC II/peptide liposomes as a novel means to induce T cell anergy. The possibility to prepare 'tailor-made' liposomal formulations may provide liposomes with an important advantage for applications in immunotherapy.

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1007586400631DOI Listing

Publication Analysis

Top Keywords

mhc ii/peptide
16
cell anergy
12
liposomes
9
liposomes incorporated
8
ii/peptide complexes
8
small unilamellar
8
unilamellar liposomes
8
liposomes absence
8
mhc ii/
8
ii/ peptide
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!